This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum - Top-Institutions - MDSpire

This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum

Revolution’s KRAS breakthrough, strong ADC signals from GSK, and shifting regulatory and dealmaking dynamics define this week in biopharma

  • April 21, 2026

  • 4 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Translational Cancer Research
    • Targeted Therapies

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Drug Development
    • Antibody-Drug Conjugates

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cancer Therapeutics
    • Clinical Trials
    • Molecular Oncology

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Cancer Biology
    • Targeted Therapy Development
    • Clinical Oncology

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Cancer Therapeutics
    • Immuno-Oncology
    • Drug Development

Original Source(s)

This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum

  • April 21, 2026

Related Content

Futile Radiotherapy for Patients With Cancer Near the End of Life

L-arginine metabolism in breast cancer: mechanisms and therapeutic targets

Oncology Organization and Oncologist Networks Under Medicare Advantage Plans